Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Bevacizumab and interferon reduce venous recanalization following sclerotherapy.

Kulungowski AM, Hassanein AH, Foster CC, Greene AK, Fishman SJ. Bevacizumab and interferon reduce venous recanalization following sclerotherapy. J Pediatr Surg. 2016 Oct; 51(10):1670-3.

View in: PubMed

collapse authors with profiles


Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)